[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100163446":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":17,"centralContacts":17,"locations":25,"responsibleParty":112,"collaborators":17,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":17,"eligibilityCriteria":120,"healthyVolunteers":116,"sex":121,"minAge":122,"maxAge":17,"enrollmentInfo":123,"targetDuration":17,"studyType":126,"phases":127,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":136,"whyStopped":17,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"Izun Pharma Ltd","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active oral rinse","EXPERIMENTAL","Oral rinse containing botanical extracts",[13],"Drug: IZN-6N4",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo rinse","PLACEBO_COMPARATOR",null,[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":17},"DRUG","IZN-6N4","Oral rinse containing 1% botanical extracts, 15 cc rinse 3 times per day, for up to 9 weeks",[9,15],[26,39,48,57,63,73,81,89,98,103],{"facility":27,"status":17,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":17},"UF Health Cancer Center","Gainesville","Florida","32610","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-82.32483,29.65163,{"lat":37,"lon":36},{"facility":40,"status":17,"city":41,"state":29,"zip":42,"country":31,"countryCode":32,"cosmosGeoPoint":43,"geoPoint":47,"contacts":17},"University of Miami-Sylvester CCC Clinical Research Services","Miami","33136",{"type":34,"coordinates":44},[45,46],-80.19366,25.77427,{"lat":46,"lon":45},{"facility":49,"status":17,"city":50,"state":50,"zip":51,"country":31,"countryCode":32,"cosmosGeoPoint":52,"geoPoint":56,"contacts":17},"Mount Sinai Beth Israel - Phillips Ambulatory Care Center","New York","10003",{"type":34,"coordinates":53},[54,55],-74.00597,40.71427,{"lat":55,"lon":54},{"facility":58,"status":17,"city":50,"state":50,"zip":59,"country":31,"countryCode":32,"cosmosGeoPoint":60,"geoPoint":62,"contacts":17},"NYU Clinical Cancer Center","10016",{"type":34,"coordinates":61},[54,55],{"lat":55,"lon":54},{"facility":64,"status":17,"city":65,"state":17,"zip":17,"country":66,"countryCode":67,"cosmosGeoPoint":68,"geoPoint":72,"contacts":17},"Soroka Medical Center","Beersheba","Israel","IL",{"type":34,"coordinates":69},[70,71],34.7913,31.25181,{"lat":71,"lon":70},{"facility":74,"status":17,"city":75,"state":17,"zip":17,"country":66,"countryCode":67,"cosmosGeoPoint":76,"geoPoint":80,"contacts":17},"Rambam Medical Center","Haifa",{"type":34,"coordinates":77},[78,79],34.99928,32.81303,{"lat":79,"lon":78},{"facility":82,"status":17,"city":83,"state":17,"zip":17,"country":66,"countryCode":67,"cosmosGeoPoint":84,"geoPoint":88,"contacts":17},"Rabin Medical Center - Beilinson Campus","Petah Tikva",{"type":34,"coordinates":85},[86,87],34.88747,32.08707,{"lat":87,"lon":86},{"facility":90,"status":17,"city":91,"state":17,"zip":92,"country":66,"countryCode":67,"cosmosGeoPoint":93,"geoPoint":97,"contacts":17},"Sourasky Medical Center","Tel Aviv","64239",{"type":34,"coordinates":94},[95,96],34.78057,32.08088,{"lat":96,"lon":95},{"facility":99,"status":17,"city":91,"state":17,"zip":17,"country":66,"countryCode":67,"cosmosGeoPoint":100,"geoPoint":102,"contacts":17},"Assuta Medical Center",{"type":34,"coordinates":101},[95,96],{"lat":96,"lon":95},{"facility":104,"status":17,"city":105,"state":17,"zip":106,"country":66,"countryCode":67,"cosmosGeoPoint":107,"geoPoint":111,"contacts":17},"Sheba Medical Center","Tel Litwinsky","52621",{"type":34,"coordinates":108},[109,110],34.84588,32.05096,{"lat":110,"lon":109},{"type":113,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100163446","phase-2-safety-and-efficacy-of-izn-6n4-oral-rinse-for-the-prevention-of-oral-mucositis-in-patients-with-head-and-neck-cancer-100163446",false,"NCT01400620","Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer","Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer","Inclusion Criteria:\n\n* diagnosis of head and neck cancer\n* planned treatment course to include Cisplatin and radiation therapy, cumulative prescription dose between 50-70 Gy\n* able to eat at least soft solids\n* normal cardiac function\n* able to perform oral rinse\n\nExclusion Criteria:\n\n* Induction chemotherapy regimen\n* life threatening allergic reaction to food and\u002For drugs\n* history of any other primary malignancy diagnosed within the past 5 years\n* prior radiation to the sites to be treated\n* active infections of the oral cavity","ALL","18 Years",{"count":124,"type":125},110,"ACTUAL","INTERVENTIONAL",[128],"PHASE2","The purpose of this study is to determine whether an oral rinse composed of botanical extracts is effective in the prevention of severe inflammation of the lining of the oral cavity caused by chemotherapy and radiation therapy for head and neck cancer.",[131],"Oral Mucositis",[133,134,135],"oral mucositis","chemoradiation","head and neck cancer","COMPLETED","2018-03-12",{"date":139,"type":125},"2018-03-13",{"date":141,"type":17},"2012-03",{"date":143,"type":125},"2017-01",{"name":5,"class":6},10]